Zoetis Launches Portela® (relfovetmab) in Canada and the European Union
PARSIPPANY, N.J.--(BUSINESS WIRE)--Jul 22, 2026-- Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor (NGF) …